Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in cN0 Breast Cancer: Impact of HER2-Positive Status on Survival

Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in cN0 Breast Cancer: Impact of HER2-Positive Status on Survival

Objective: High rates of negative sentinel lymph node biopsy (SLNB) in clinically node-negative (cN0) breast cancer (BC) after neoadjuvant chemotherapy (NAC) have been described. These results are associated with triple-negative (TNBC) and human epidermal growth factor receptor 2 (HER2+) subtypes ac...

Full description

Bibliographic Details
Main Authors: Juan Alors-Ruiz, Salomé Sanz-Viedma, Francisco Javier Fernández-Garcia, Francisco Sendra-Portero
Format: Article
Language:English
Published: Galenos Publishing House 2024-04-01
Series:European Journal of Breast Health
Subjects:
her-2/neu
neoadjuvant chemotherapy
sentinel lymph node biopsy
survival
triple negative breast cancer
Online Access: http://www.eurjbreasthealth.com/archives/archive-detail/article-preview/sentinel-lymph-node-biopsy-after-neoadjuvant-chemo/64792

Internet

http://www.eurjbreasthealth.com/archives/archive-detail/article-preview/sentinel-lymph-node-biopsy-after-neoadjuvant-chemo/64792

Similar Items